MANUFACTURING CAPABILITIES AND CAPACITIES

The characteristics of Saibins Pharmaceuticals manufacturing facilities are:

  • Total covered area is 6 kanal i.e. 12000 approved with cGMP standards.
  • Manufacturing under cGMP regulations.
  • Highly qualified professional and experienced technical staff.
  • HVAC system to control temperature, humidity, pressure and central dust collection system to avoid cross contamination.
  • Control lab with worldwide used delicate and latest equipments.
  • ISO 9001-2008 Certified.
  • Production Capacity.
  • 100 million tablets per annum.
  • 14 million capsule per annum.

ENVIRONMENT & HYGIENE POLICY

Saibins Pharmaceuticals Corporate Policy on Environmental & Hygiene Management System outlines an organizational framework for improvement of environmental impacts and aspects. The salient features of our policy are:

  • All personnel should receive medical examination upon recruitment.
  • Steps should be taken to ensure as far as is practicable that no person affected by an infectious disease or having open lesions on the exposed surface of the body is engaged in the manufacture of medicinal products.
  • Every person entering the manufacturing areas should wear protective garments appropriate to the operations to the carried out.
  • Eating, drinking, chewing or smoking, or the storage of food, drink smoking materials or personal medication in the production and storage areas is prohibited.
  • Training our people with a view to creating awareness among them about the importance of a pollution – free environment.
  • Complying with regulations and environmental laws.

QUALITY CONTROL DEPARTMENT

Saibins Pharmaceutical has a strong and well established Quality Control Department. The system of Quality Assurance appropriate for the manufacture of medicinal products should ensure that:

  • All necessary controls on intermediate products and any other in-process controls and validations are carried out.
  • Medicinal products are not sold or supplied before a Qualified Person has certified that each production batch has been produced and controlled in accordance with the requirements of the Marketing Authorization.
  • Satisfactory arrangements exist to ensure as far as possible, that the medicinal products are stored, distributed and subsequently handled so that quality is maintained throughout their shelf life.